|
Vicki,
In addition to Dacogen, which Neil references, there are a couple of drugs that are both in clinical trials, but are showing pretty good results for MDS patients where Vidaza has been discontinued. The first one is Sapacitabine, and the other is Rigosertib (trade name Estybon). I believe both of these are in phase III trials currently.
There are several other drug options that people on this forum are trying.
You may want to discuss all options with your doctor to see if any of these paths are right for your situation.
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
|